Abstract
This management report analyses the structure, performance, R&D and products
of 60 leading cardiovascular device manufacturers.
Cardiovascular disease is not only the biggest cause of death worldwide, but
is also responsible for a significant proportion of health complications
requiring long-term management. With ageing populations and concerns about
obesity and unhealthy lifestyles, it is clear that the cardiovascular sector
has a role to play in lowering health costs and providing better patient
outcomes.
As a result, the medical industry has responded in what is becoming a fiercely
competitive sector through better-tolerated and more reliable devices
utilising new technology and biomaterials. In 2007, a raft of mergers and
acquisitions have taken place and the FDA' s long-awaited approval of
Medtronics' Endeavour is expected to energise the drug eluting stent sector.
Leading players such as Abbott, Cordis and Boston Scientific may have the
sales resources to dominate, but can smaller or emerging companies have input
too?
That is why Espicom has published a fully-updated, November 2007 2nd edition
of its popular report Who' s Developing What in Cardiovascular Devices?
The new expanded edition provides comprehensive analysis of 60 leading players
in the global cardiovascular device industry. Subjects covered for each
company include:
- Company Overview
- Key Personnel
- Key Milestones
- Competitior Analysis
- Products/Technologies R&D and Research Strategy
- Key Agreements and Alliances
- Financial Data
- Comprehensive Contact Details
View Cart
